Local treatment
Sponsors
Tongji Hospital, Junjie Peng, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Nanjing Tianyinshan Hospital, The First Hospital of Jilin University
Conditions
Advanced Colorectal CancerBreast CancerCirculating Tumor DNAEffects of ImmunotherapyHepatocellular CarcinomaHepatocellular Carcinoma(HCC)MRDProgrammed Cell Death 1
Phase 2
Unknown Phase
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC
NCT05420922
Start: 2021-11-01End: 2022-12-31Target: 2000Updated: 2022-06-15
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules
NCT05495672
Start: 2022-08-01End: 2025-12-01Target: 100Updated: 2022-08-10
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
RecruitingNCT06893887
Start: 2025-05-22End: 2028-03-15Target: 300Updated: 2025-07-02
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
RecruitingNCT06918262
Start: 2024-01-01End: 2027-10-31Target: 40Updated: 2025-04-09